Stable Biologics

Stable Biologics transforming the development of protein-based therapeutics and vaccines with our advanced technology platform. Our tiered screening system helps solve the complex challenges of protein solubility, stability, and delivery, enabling faster and more cost-effective formulation optimization. Using Automated High Throughput Self-Interaction Chromatography (HSC™), we accelerate the identification of optimal formulations by measuring key metrics like the Second Virial Coefficient (B-value) to assess protein-protein interactions. Our platform reduces the time, cost, and manpower traditionally required for formulation optimization, cutting timelines from years to months and saving hundreds of thousands of dollars. Key Benefits: Faster Time to Market: Streamline formulation development. Cost-Effective: Reduce R&D costs and resource requirements. Improved Performance: Optimize solubility, stability, and delivery of protein drugs. Stable Biologics is your partner in rapidly advancing protein-based therapies, with the speed and efficiency needed to bring life-saving treatments to market.